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ABSTRACT 
Background: The introduction of pipeline embolisa-
tion device (PED) has improved the feasibility of en-
dovascular treatment of intracranial aneurysms. The 
device allows for endoluminal reconstruction across 
the aneurysm neck but is permeable enough that flow 
is preserved across the pressure gradients into side- 
branch arteries. In spite of higher rates of aneurysm 
occlusion, there is lack of data concerning medium to 
long-term clinical and imaging results. Methods: This 
study was a prospective single center analysis of com-
plications, imaging results, and medium term clinical 
outcomes after PED treatment of intracranial aneu-
rysms. We included cases over a 17-month period in a 
tertiary interventional neuroradiology center. We 
collected data on demographics, vascular risk factors, 
clinical presentation, angiographic results post treat-
ment, angiographic follow-up and clinical follow-up. 
Results: Thirty-three patients were included, 25 fe-
males and 8 males, with mean age of 55 years; 3 pre-
sented with acute subarachnoid hemorrhage and 30 
for elective treatment. Thirty-seven aneurysms were 
treated: 35 Internal Carotid Artery (ICA), 1 basilar 
trunk fusiform, and 1 vertebral artery intradural 
dissecting aneurysms. No deaths have occurred. Five 
patients suffered transient neurological complications 
(15%). Overall aneurysm occlusion was demonstrat-
ed in 85% of patients at the end of one year. Discus-
sion: Overall, the technique of flow diversion and 
endoluminal reconstruction differs greatly from the 
established endosaccular packing techniques of stan-
dard coiling, balloon remodeling, or stent assisted 
coiling. Our midterm follow-up confirms that, the 
rates of clinically significant complications compare 
favorably with published data on stent assisted coiling, 
potentially making these devices a truly revolutioniz-
ing technique. 
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1. INTRODUCTION 
The introduction of flow-diverting or flow-directing de-
vices is a significant addition to the endovascular treat-
ment of intracranial aneurysms. These stent-like devices 
are deployed in the parent artery to treat aneurysms by 
endoluminal reconstruction across the aneurysm neck, 
with or without endosaccular coil embolization. The 
mesh wall of the device is dense enough to disrupt flow 
in and out of the aneurysm sac leading to stasis and 
thrombosis; but permeable enough that flow is preserved 
across the pressure gradients into side-branch arteries. 
Over a longer period the device acts as scaffolding on 
which new endothelium forms, thereby reconstructing 
the parent artery and excluding the aneurysm from the 
circulation. 
The pipeline embolization device (PED, ev3 Califor-
nia) is a self-expanding cylindrical device composed of 
48 braided strands of cobalt chromium and platinum, 
each 28 - 33 μm in calibre. When fully deployed, the 
device expands to its nominal caliber and shortens by a 
factor of 2.5 to its nominal length. When unrestrained, a 
single PED has 30% - 35% metal surface area coverage, 
or porosity. 
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Although several large case series have been published, 
there is a paucity of long-term clinical and imaging fol-
low-up in the literature, in which two of the few pub-
lished series to date with greater than one year follow-up 
are of 12 and 18 patients respectively [1,2]. Initially the 
published data focused on ischemic events, in-construct 
stenosis, mass effect, and delayed aneurysm rupture [2-4], 
however more recently a subset of unusual hemorrhagic 
events after PED have surfaced [5-10]. 
This study was a prospective single center analysis of 
complications, imaging results, and long-term clinical 
outcomes after PED treatment of anterior and posterior 
circulation aneurysms in 33 patients. 
2. MATERIALS AND METHODS 
2.1. Patient Selection 
Data was prospectively recorded for all cases where PED 
was used over a 17-month period in tertiary interven-
tional neuroradiology center. Case selection was made on 
the basis of aneurysm morphology for which standard 
balloon-remodeling, stent-assisted, and neurosurgical 
techniques are not suitable or have been unsuccessful. 
The decision to treat with PED was by consensus opinion 
at a multidisciplinary meeting involving interventional 
neuroradiologists and subspecialist cerebrovascular neu-
rosurgeons. 
2.2. Procedural Methods 
2.2.1. Antiplatelet Therapy 
T All patients were pre-medicated with dual antiplatelet 
therapy. The 30 booked elective cases were prescribed 75 
mg Clopidogrel and 100 mg aspirin for 3 days minimum. 
The 3 acute cases were given 450 mg clopidogrel and 
300 mg aspirin 4 - 5 hours before the operation. All cases 
were prescribed 6 months of 75 mg clopidogrel and life-
long 100 mg aspirin postoperatively. 
2.2.2. Anticoagulation 
In 32 cases the patient was heparinized after the common 
femoral artery was accessed. In the case of the recently 
ruptured dissecting blister Internal Carotid Artery (ICA) 
aneurysm, anticoagulation was delayed until the aneu-
rysm was coiled. All patients were prescribed a heparin 
infusion for 48hrs post operatively. 
2.2.3. Neurointerventional Procedure 
All cases were performed under general anesthetic. 
Standard neurointerventional co-axial or tri-axial access 
delivery systems were used. A jailed microcatheter tech-
nique was employed if endosaccular coiling was being 
performed. The PED deployment technique has been 
previously described [3,11]. 
2.3. Clinical Follow-Up 
All patients were assessed on multiple occasions by in-
terventional neuroradiologists in outpatient clinic; the 
minimum number of visits was 3; at 6 - 8 weeks, at 6 
months, and at 12 months. Additional clinical follow-up 
during and after these timeframes were used when clini-
cally indicated. Their neurological outcome was assessed 
on the modified Rankin Scale. 
2.4. Imaging Follow-Up  
The imaging follow-up regimen varied, depending on the 
other intracranial devices present, logistical factors (pa-
tients in remote areas) and the patient’s preferences. 
Catheter angiography remains the gold standard, but 
other non-invasive imaging modalities can also evaluate 
stent patency and aneurysm occlusion. 
CT Angiography (CTA) can demonstrate stent patency 
and aneurysm occlusion when no endosaccular coils are 
present. Other authors have also reported this [12,13]. 
Using an edge-enhancing high-spatial-resolution kernel 
(H60s or H60f) anecdotally results in better delineation 
of device patency, aneurysm filling, and aneurysm mor-
phology. Use of edge-enhancing high resolution kernels 
to assess stent patency has been reported in CT coronary 
angiography [14]. 
MRI and MR Angiography (MRA) are less affected by 
coil artifact, can demonstrate endosaccular thrombus, 
and can exclude aneurysm filling. MRI/MRA is however 
more limited in imaging the device lumen, and T1 hy- 
perintense endosaccular clot can occasionally result in 
the false appearance of blood flow on time-of-flight 
MRA. 
3. RESULTS 
3.1. Patient Demographics 
33 consecutive patients (25 females, ratio 3.1:1), with 
mean age 55 years were treated with PED between Sep-
tember 2009 and February 2011.  
3.2. Clinical Presentations 
3.2.1. Three Acute Presentations 
Patient 13 was a 49-year-old male who presented with 
acute and sudden onset left retro-orbital pain, swelling, 
and double vision. On examination he had cranial nerves 
III, IV, and VI palsies, chemosis, and proptosis. A cathe-
ter cerebral angiogram on day 0 demonstrated a direct 
left carotid-cavernous fistula secondary to a ruptured 
cavernous segment ICA aneurysm. After on-table 450 
mg clopidogrel and 300 mg aspirin, two PEDs were used 
to create a flow-diverting construct across the aneurysm 
neck. This acutely reduced the fistulous flow on-table. 
Coil embolization of the cavernous sinus was performed 
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on day 0, day 4, and at 8 months; with complete occlu-
sion of the fistula. At 18 months he had no signs of caro-
tid cavernous fistula (no chemosis, proptosis, venous en- 
gorgement or retinal hemorrhages), but persistent double 
vision. See Figure 1. 
Patient 15 was a 30-year-old female who presented 
with World Federation of Neurosurgery (WFNS) clinical 
grade 2, Fisher CT grade 2 subarachnoid hemorrhage. 
No intracranial lesion was detected on three catheter an-
giograms and MR angiography between days 0 and 7. 
Multiple extracranial and extradural carotid and vertebral 
artery dissections, and fibromuscular dysplasia were ob-
served. Repeat MRI and catheter angiography performed 
on day 17 and 18 demonstrated a newly apparent left 
supraclinoid ICA lateral side-wall 3.5 mm blister aneu-
rysm. On day 29 the aneurysm had enlarged to 5 mm and 
was treated with endosaccular coiling and a single PED 
construct. On-table aneurysm rupture complicated the 
endosaccular coiling prior to PED deployment. The sub-
arachnoid extravasation resolved without any change in  
 
 
Figure 1. All images are digital subtracted angiograms from a 
left internal carotid artery injection, during the arterial phase, in 
Patient 13. a) Day 0 after rupture of a cavernous ICA aneurysm 
with resultant acute carotid-cavernous fistula. Arrowhead indi-
cating the cavernous aneurysm and the abnormal opacification 
of the cavernous sinus. Black arrow indicating the abnormal 
filling of the inferior petrosal sinus, and a white arrow indicat-
ing the filling of the superior ophthalmic vein; b) Day 0 after 
deployment of a flow-diverting construct (3 PEDs) in the ca-
vernous ICA, demonstrating less rapid filling of the cavernous 
sinus and delayed emptying of the aneurysm (black arrowhead), 
less rapid filling of the inferior petrosal sinus, and absent filling 
of the superior ophthalmic vein in the arterial phase; c) Repeat 
angiography on day 6 demonstrating increased superior oph-
thalmic vein filling and dilatation (white arrow), expansion and 
increased filling of the cavernous sinus (black arrowhead), and 
cortical venous reflux (black arrow); d) Follow-up angiography 
at 1 year after three further trans-venous cavernous sinus coil-
ings (arrowheads). No abnormal fistulous filling of the cavern-
ous sinus, ophthalmic veins, inferior petrosal sinus, or cortical 
veins is demonstrated in the arterial phase. 
clinical parameters, and PED deployment was completed. 
The patient awoke with a headache post procedure but 
was otherwise neurologically unchanged. At 6 months 
she is back at work, mRS 0, and follow-up MRA demon-
strates no aneurysm filling. 
Patient 29 was a 78-year-old male patient presenting 
with an acute painful third cranial nerve palsy secondary 
to an 8 mm wide necked posterior communicating artery 
aneurysm. Coiling on day 1 was partially successful, 
with only one coil deployed. On day 4, after clopidogrel 
loading, two PEDs were deployed across the aneurysm 
neck. CTA on day 7 demonstrated complete aneurysm 
occlusion. The patient’s headache and eye pain resolved 
by day 10. At 6 month clinical follow-up the complete 
third cranial nerve palsy remains, but he is pain free. 
3.2.2. Thirty Electively Booked Cases 
1) Baseline neurological status 
28 of these patients were either asymptomatic, or not 
disabled by their symptoms (modified Rankin Scale, 
mRS = 0 or 1) pre-operatively. Patients 3 and 33 were 
disabled secondary to their original poor clinical grade 
subarachnoid hemorrhage and had mRS scores of 3 and 4 
pre-operatively. 
2) Previously treated aneurysms 
Twelve patients were treated electively for aneurysm 
recanalisation or recurrence after prior treatment; 8 had 
been previously coiled only, 1 coiled and clipped, 1 
coiled with stent assistance and clipped, and 2 had been 
clipped only. Seven had originally presented with target 
aneurysm rupture and subarachnoid hemorrhage. Two 
originally presented with cranial nerve palsies. 
3) Unruptured aneurysms not previously treated 
18 cases were elective treatment of unruptured and 
previously untreated aneurysms with PED. Four of these 
cases presented with cranial nerve palsy.  
3.3. Aneurysms 
Thirty-seven aneurysms were treated in 33 patients. Pa-
tient 12 had an unruptured ophthalmic segment aneurysm 
treated in combination with a previously coiled superior 
hypophyseal aneurysm arising from the same ICA. In 
Patient 14, 4 left ICA aneurysms were treated in a single 
procedure. 
Thirty five ICA aneurysms (7 cavernous, 28 intradur-
al), one basilar trunk fusiform/side-wall aneurysm, and 1 
vertebral artery intradural dissecting aneurysm were 
treated. The mean aneurysm size was 9.0 mm, 13 were 
large (≥10 mm), and 30 were broad based (neck width ≥4 
mm and/or dome to neck ratio < 1.6). 
3.4. Procedural Results 
3.4.1. PED Constructs 
In 27 patients a single PED was deployed across the 
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aneurysm neck. In 6 cases two telescoping PEDs were 
deployed. 
3.4.2. Coils with PED 
Endosaccular coils were deployed during the same pro-
cedure as PED deployment in 5 patients. In 4 cases this 
was to increase aneurysm stasis.  
Coils were used for a more novel reason in Patient 3, 
who was a 50-year-old female with a 26mm wide-necked 
carotid-ophthalmic aneurysm that had previously been 
coiled after poor clinical grade SAH, and re-packed on 
two occasions. The rapid flow into the wide neck made 
navigation of the Marksman microcatheter past the aneu- 
rysm neck difficult. Endosaccular coils were deployed 
which successfully prevented the Marksman microca-
theter from prolapsing into the aneurysm sac. See Figure 
2. 
3.4.3. PED Deployment 
Deployment of the PED construct was achieved in all 
cases.  
However, noteworthy difficulties were encountered in 
two cases: 
In Patient 3, two PEDs were deployed across the wide 
aneurysm neck. The distal bumper of the second (prox-
imal) PED delivery wire became trapped at the distal end 
of the first (distal) PED. Manipulation of the delivery 
wire resulted in the distal bumper detaching but remain-
ing firmly adhered to the PED. No embolic or ischemic 
complications were detected on imaging and the patient 
suffered no clinical adverse event. On Digital Subtraction  
 
 
Figure 2. All images are digital subtraction angiography, right 
internal carotid artery injection, in Patient 3. a) Day 0. A giant 
ICA aneurysm presented with WFNS grade 5 subarachnoid 
hemorrhage; b) This was coiled on day 0; c) at 24 months sig-
nificant coil compaction and recanalization occurred despite 2 
elective repeat coilings and unsuccessful surgical exploration; d) 
6 months after deployment of a dual PED construct, the aneu-
rysm is completely occluded and the coil mass is collapsing 
toward the parent ICA. 
Angiography (DSA) at 6 months the detached bumper 
has not moved. 
Patient 6 was a 33-year-old female with an ophthalmic 
segment ICA aneurysm that had recurred after neurosur-
gical clipping and endovascular stent assisted coiling. 
During PED deployment the device failed to self-expand 
in its middle section, creating an hourglass configuration 
that temporarily obstructed forward flow in the parent 
ICA. This was remedied with balloon angioplasty, which 
successfully opened the PED and restored normal ICA 
flow. The patient was therapeutically anticoagulated 
throughout the procedure, had cross-flow via patent an-
terior and posterior communicating arteries, had no 
ischemic lesion on post-procedure imaging, and suffered 
no clinical adverse event. 
3.4.4. Immediate Angiographic Results 
Varying degrees of sluggish emptying of contrast from 
the aneurysm were observed at the end of the case. A “jet” 
like appearance of aneurysm filling was not demonstrat-
ed at the completion of any procedure.  
3.4.5. Repeat Treatments 
Three patients had repeat treatments: 
Patient 5 was a 58-year-old male with an unruptured, 
previously untreated 5mm wide necked paraclinoid ICA 
aneurysm that was treated with a single PED. At 9 
months the aneurysm was still filling and a second PED 
was deployed at 10 months. Three months after the 
second treatment aneurysm occlusion was demonstrated 
on DSA. 
In Patient 16, a 76-year-old female, a single PED was 
used to electively treat recanalisation of a previously 
coiled right posterior communicating artery aneurysm. 
The patient had originally presented with acute painful 
third nerve palsy, cured by the original coiling. The day 
following the PED procedure the patient suffered a new 
acute painful third cranial nerve palsy. CT and MRI per-
formed to investigate this demonstrated a small punctate 
focus of intraparenchymal hemorrhage in the ipsilateral 
temporal lobe. She had no symptoms attributable to this 
lesion. Due to concern that the nerve palsy represented 
pressurization of the aneurysm, two more PEDs were 
deployed on day 2. Aneurysm emptying was much slow-
er and the painful third nerve palsy resolved within 48 
hours. 
Patient 7 was a 64-year-old female with persistent 
filling of a wide-necked supraclinoid ICA aneurysm one 
year after PED treatment. At 13 months a second PED 
was deployed, and 4 months later the aneurysm is still 
filling. 
3.4.6. Complications 
No deaths have occurred; however, five patients (15%) 
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suffered transient neurological complications: 2 transient 
ischemic attacks, 1 intra-procedural SAH, 1 delayed 
SAH, and 1 exacerbation of mass effect. 2 patients (6%) 
suffered permanent neurological complications; 1 de-
layed stroke and 1 mass effect exacerbation causing per- 
manent ophthalmoplegia.  
A clinically silent complication was documented on 
imaging in 1 patient (3%), and a single patient (3%) suf-
fered an asymptomatic femoral artery complication. 
3.4.7. Procedural Complications 
Intra-procedural Aneurysm Rupture and SAH: 
Intra-procedural aneurysm rupture occurred during 
adjunctive aneurysm coiling in patient 15, discussed 
above. Other than headache there was no clinical sequel.  
3.4.8. Clinical Complications 
1) Exacerbation of mass effect causing cranial nerve 
palsies (2 patients): 
Patient 16, discussed above, had a new painful third 
cranial nerve palsy on day 1 post PED treatment. Dep-
loyment of two more PEDs occluded the aneurysm and 
cured the palsy. 
Patient 23 was a 41-year-old female who suffered 
painful third, fourth, sixth, and fifth cranial nerve palsies 
after treatment of a giant cavernous ICA aneurysm with a 
PED construct. The aneurysm had initially presented 
with intermittent ophthalmoplegia. Her new symptoms 
began 24 hours after the PED deployment, and a CTA 
performed on the same day demonstrated occlusion of 
the treated aneurysm. This chronology suggests that the 
aneurysm thrombosis induced the new cranial nerve pal-
sies. At one year the pain has resolved and the ophthal-
moplegia is improving. She is independent and back at 
work. Her modified Rankin score is 1. 
2) Transient ischemic attacks (2 patients): 
Two patients had transient neurological deficits within 
24 hours of PED deployment. Patient 4 was a 72-year- 
old female with a wide necked cavernous ICA aneurysm 
causing a third cranial nerve palsy. 8 hours after two 
PEDs were deployed, she developed arm weakness and 
was treated with intra-arterial and intravenous Abcix-
imab.  
Angiography demonstrated aneurysm occlusion and 
no detectable branch occlusion. The weakness resolved 
completely, with no infarct detected on MRI. 
In Patient 3 discussed above, her arm weakness oc-
curred in the first 24 hours and resolved spontaneously. 
3) Stroke: 
Patient 30 was a 65-year-old female with an unrup-
tured 12 mm irregular basilar fusiform/side-wall aneu-
rysm. The first PED shortened more than anticipated and 
did not cover the length of the aneurysm, so a second 
PED was deployed with approximately 10 mm of over-
lap between the two devices. Her perioperative in-hos- 
pital course was uneventful and she was asymptomatic at 
discharge on day 3. On day 11 she represented to hospit-
al with left sided weakness and an MRI demonstrated 
bilateral pontine infarcts. The aneurysm had almost en-
tirely thrombosed. The chronology of the stroke suggests 
that the affected pontine perforating arteries occluded 
when the aneurysm thrombosed. At one year she remains 
mildly disabled with lower limb weakness and ataxia. 
Her modified Rankin score is 2. Her imaging is demon-
strated in Figures 3 and 4. 
4) Delayed SAH: 
Patient 7, a 64-year-old woman, represented to hospit-
al with headache and nausea 3 days after elective PED 
treatment of a wide necked unruptured 11 mm ICA 
aneurysm. A non-contrast brain CT and an MRI demon-
strated a small focus of SAH in a parietal sulcus, ipsila-
teral but remote from the aneurysm site. The patient’s 
symptoms resolved uneventfully, and she remains asym- 
ptomatic at 6 month follow-up. See Figure 5. 
5) Asymptomatic Intraparenchymal hemorrhage: 
Patient 16, discussed above, had an asymptomatic 
punctate contralateral temporal lobe hemorrhage demon-
strated on CT and MRI on day 1 post PED treatment. See 
Figure 5. 
6) Lower limb complications: 
In Patient 15, discussed above, an asymptomatic short 
segment common femoral artery occlusion was demon-
strated on ultrasound at day 35. This has remained asym- 
ptomatic at 6-month follow-up. 
 
 
Figure 3. All images are digital subtraction angiography, ver-
tebral artery injection, in Patient 30. a) AP and b) lateral pro-
jection demonstrating an an unruptured 12 mm irregular basilar 
fusiform/side-wall aneurysm; c) AP and d) lateral images de-
monstrating contrast stagnation after placement of two PEDs. 
The first PED shortened more than anticipated and did not 
cover the length of the aneurysm, so a second PED was dep-
loyed with approximately 10mm of overlap between the two 
devices. Her perioperative in-hospital course was uneventful 
and she was asymptomatic at discharge on day 3. 
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Figure 4. Patient 30 (continued from Figure 3). On day 11 she 
represented to hospital with left sided weakness. a) and b) axial 
diffusion weighted MR images demonstrating bilateral pontine 
infarcts; c) AP and d) lateral digital subtraction angiograms 
demonstrated that the aneurysm had almost entirely throm-
bosed. The chronology of the stroke suggests that the affected 
pontine perforating arteries occluded when the aneurysm 
thrombosed. At one year she remains mildly disabled with 
lower limb weakness and ataxia. Her modified Rankin score is 
2. 
 
 
Figure 5. Both images are axial non-contrast brain CT studies, 
in different patients. a) Patient 16 had an asymptomatic punc-
tate contralateral temporal lobe hemorrhage demonstrated on 
CT and MRI on day 1 post PED treatment; b) Patient 7, a 
64-year-old woman, represented to hospital with headache and 
nausea 3 days after elective PED treatment of a wide necked 
unruptured 11 mm ICA aneurysm. A non-contrast brain CT 
demonstrated a small focus of SAH in a parietal sulcus, ipsila-
teral but remote from the aneurysm site. The patient’s symp-
toms resolved uneventfully, and she remains asymptomatic at 
6-month follow-up. 
3.5. Imaging Follow-Up Results 
3.5.1. Imaging Modalities 
All patients have had a minimum of 6 month follow im-
aging. 28 patients had follow-up angiograms, and 5 pa-
tients have been followed up with a combination of CTA 
and MRA without catheter angiography. 
3.5.2. In-Construct Intimal Hyperplasia 
Patient 32 was a 44-year-old female with an enlarging 
neck remnant associated with a previously coiled supe-
rior hypophyseal aneurysm, originally presenting with 
SAH. Angiography 6 months after treatment with a sin-
gle PED construct demonstrated aneurysm occlusion and 
mild in-construct intimal hyperplasia, with <25% steno-
sis. Her clopidogrel was ceased and her aspirin contin-
ued. 
3.5.3. Aneurysm Occlusion 
In 28 patients (85%) occlusion of the treated aneurysm(s) 
has been demonstrated. Of these, 6 (21%) were demon-
strated at less than 30 days, 16 (57%) at less than 6 
months, and 25 (89%) within one year. In 3 cases (11%) 
aneurysm occlusion was first demonstrated at greater 
than one year post treatment.  
In two of these cases (Patient 9 and Patient 16) this 
was the earliest angiogram post PED treatment, due to 
patient choice. Patient 5, discussed above, was re-treated 
with a second PED on day 315 and occlusion was then 
demonstrated n day 396 after the first PED treatment. 
3.5.4. Persistent Aneurysm Filling 
The neck remnant of the ophthalmic segment ICA aneu-
rysm treated with 2 PEDs in Patient 6, discussed above, 
had reduced in size and significantly slower endosaccular 
flow was demonstrated at 7 months and 16 months. This 
aneurysm had been previously treated with Neuroform 
(Stryker Neurovascular, California) stent assisted coiling, 
which has been previously reported to reduce the inci-
dent of aneurysm closure [3,6,7,15]. A patent ophthalmic 
artery was still also filling from the aneurysm.  
Patient 7 is discussed above. 
Patient 12 was a 40-year-old female treated electively 
with a single PED for two aneurysms arising from the 
left ICA. On day 211 the previously untreated ophthal-
mic segment aneurysm had occluded, and the recanalised 
neck of the previously coiled superior hypophyseal 
aneurysm had reduced in size with the coil mass col-
lapsing down towards the PED.  
In Patient 17, a 72-year-old female, an unruptured 
16mm cavernous segment ICA aneurysm causing cranial 
nerve symptoms was treated with a single PED. At 6 
months the aneurysm has reduced in size to 6mm and the 
cranial nerve symptoms have resolved. 
Patient 22 was a 68-year-old female in whom a single 
PED was used to treat an unruptured wide necked 8mm 
cavernous ICA aneurysm that presented with cranial 
nerve palsy. At 1 year the aneurysm is not occluded and 
follow-up imaging is planned for 2 years post treatment. 
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3.6. Clinical Follow-Up Results 
All patients have had a minimum of 12 months clinical 
follow-up. Mean follow-up is 21 months (range 13 to 32 
months). No deaths have occurred. The clinical status 
and modified Rankin Score (mRS) has not changed from 
its preoperative state in 31 cases (94%). 
Patient 23, discussed above, has persistent ophthal-
moplegia which is not disabling and she is back at work, 
her mRS equals 1. 
Patient 30 remains disabled by her pontine stroke, but 
is independent. Her mRS equals 2. 
4. DISCUSSION  
1) PED deployment: 
As the collective operator experience increases, the 
deployment technique has evolved from a predominantly 
“unsheathing” method as used for most other stents, to a 
more balanced “push and pull” method with more for-
ward load on the PED delivery device. Anecdotally this 
increases the wall apposition and distal anchorage of the 
PED, reducing the incidence of the device slipping 
proximally during the unsheathing of its remainder. We 
observed this in our series and this is also reported by 
authors in other recent series [6,16]. 
2) Re-capturing the distal bumper: 
After the PED is released, the microcatheter is re-ad- 
vanced over the delivery wire (inside the PED lumen) 
and the distal capture coil or bumper. This bumper has a 
larger diameter than the delivery wire and can be diffi-
cult to recapture when the system is in a tortuous seg-
ment. In a single case in our series the distal end of the 
delivery wire broke off during repeated attempts to re-
capture it. This remained stationary within the PED con-
struct at follow-up and caused no clinical sequel. Other 
authors have reported problems recapturing the distal 
bumper in as many as 26% of cases [6,16]. 
3) Use of balloon angioplasty to remodel the PED 
once deployed: 
The use of balloons such as the Hyperglide or Hyper-
form (ev3, Irvine) to assist the PED in opening com-
pletely and apposing the endothelial surface has become 
commonplace, and is described by many authors [2,5-9, 
17-19]. Fischer et al. report using this technique in 13 
(15%) of 88 patients, and the Pipeline for Uncoilable or 
Failed Aneurysms (PUFS) trial data records this in 18 
(16%) of 111 patients [5,6]. Fischer et al. also report the 
use of angioplasty to correct parent artery stenosis before 
PED deployment [6]. The technique is not without risk, 
one patient in the pipeline embolization device for the 
Intracranial Treatment of Aneurysms (PITA) trial suf-
fered an iatrogenic ICA rupture during balloon angiop-
lasty to correct a stenosis after PED deployment [4]. 
The successful use of endosaccular coils to prevent 
prolapse of the Marksman microcatheter into a giant 
aneurysm sac (Patient 3) has not previously been des- 
cribed. 
4) Aneurysm Occlusion: 
Our overall rate of demonstrated aneurysm occlusion 
was 85% which is similar to the 84% recorded in the 
PUFS trial [5], and the 85% recorded by McAuliffe et al. 
[8]. These closure rates are less than the 93% - 94% oc-
clusion rates demonstrated in the early series by Lylyk et 
al., Szikora et al., and the PITA trial [2-4]; but greater 
than the 74% in the largest published PED series to date 
[6]. 
These rates compare favorably with stent assisted 
coiling techniques. Large series of patients treated with 
laser cut scaffolding type stents record rates of 24% - 
28% incomplete aneurysm occlusion. [20,21] A series of 
19 patients treated with a more advanced Y-stenting 
technique for basilar tip aneurysms recorded aneurysm 
closure in 63% [22]. 
5) Repeat Treatments: 
Three (9%) of 33 patients in our series had repeat PED 
treatments, in one case to treat recurrent mass effect after 
an elective single PED treatment of aneurysm recanalisa-
tion, and in two cases to treat persistent aneurysm filling 
at 9 and 13 months after single PED treatment. Fischer et 
al. also recorded a 9% retreatment rate in their series 
[6].The largest series of stent assisted coiling with me-
dium term follow-up (using the Neuroform stent) re-
ported a recanalisation rate of 28% and a retreatment rate 
of 15% [20]. 
6) Thromboembolic and Ischemic complications: 
Two patients (6%) suffered transient ischemic attacks. 
One patient (3%) suffered a stroke, a pontine infarction 
that has resulted in mild/moderate disability, with pre-
served independence. In published series of greater than 
10 cases; rates of TIAs range from 0% to 17%, and 
strokes from 0% to 17% [1-8,15,16,23,24]. 
The single permanent neurological deficit in our was 
due to a basilar perforator infarction at the site of an 
overlapping double PED construct. The vertebrobasilar 
system differs embryologically from the anterior circula-
tion, and its supply to the rhombencephalon and mesen-
cephalon is via perforators arising directly from the par-
ent artery [25]. Occlusion of a single perforator can, as in 
this case, cause bilateral and disabling brainstem infarc-
tion. 
The majority of the cases published in the literature 
involve PEDs deployed in the ICA, however posterior 
circulation PED cases provide a relatively greater share 
of the ischemic complications [6,8,15,16]. Twenty two 
(25%) of the 88 patients in the series by Fischer et al. 
had posterior circulation aneurysms treated with PED. Of 
the 5 serious complications, 3 (60%) were in basilar 
aneurysm cases [6]. A silent pontine infarct was reported 
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in a basilar artery PED case by Martin et al. [19]. Recent 
case reports have documented three very late PED con-
struct occlusions in posterior circulation cases, 2 of them 
fatal [26,27]. A case report of an A1 perforator infarction 
after overlapping PEDs is also reported [28]. 
Large series of patients treated with laser cut scaffold-
ing type stents record rates of 5% - 7% permanent neu-
rological complications [20,21]. A series of 19 patients 
treated with Y-stenting technique for basilar tip aneu-
rysms recorded initial complications of 32%, and de-
layed thromboembolic complications in 11 [22]. 
7) Hemorrhagic complications: 
One case of very small volume parietal sulcal SAH at 
day 3 post ipsilateral ICA PED presented with headache 
and nausea which resolved uneventfully. One case of 
asymptomatic punctate temporal lobe hemorrhage on day 
1 post ipsilateral ICA PED was recorded. 
Intraparenchymal and non-aneurysmal SAH in the ter-
ritory supplied by the parent artery (“dependent brain”) 
are emerging as complications that are possibly peculiar 
to flow diverters.  
In the PUFS trial [4], intracerebral hemorrhages have 
been recorded in 111 cases [5]. Fischer et al. report 3 
dependent brain hemorrhages in 88 cases [6], Cruz et al. 
reported 4 intraparenchymal hemorrhages in a series of 
66.10 and single cases have been reported by several 
other authors [7,9,16]. 
In the largest series of stent assisted coiling with me-
dium term follow-up, 19 peri-procedural strokes were 
recorded in 284 patients (6.7%). Five deaths (1.8%) were 
associated with new infarctions. Five (1.8%) procedural 
perforations resulted in a new SAH. No dependent brain 
intraparenchymal hemorrhages were recorded, despite a 
similar regimen of dual antiplatelet pre-medication and 
peri-procedural heparinisation. No delayed aneurysm 
ruptures were encountered in this study. 
8) Increased Mass Effect after PED: 
Of the 7 patients who had initially presented with 
aneurysm mass effect, 2 (29%) suffered worsening ocu-
lomotor dysfunction associated with increased aneurysm 
mass effect post PED treatment. This is similar to the 
rates published by Lylyk et al. (3 of 4, 75%), McAuliffe 
et al. (3 of 16, 19%), and the PUFS trial (9 of 111, 8%) 
[3,5,8]. 
9) The use of PED in acute SAH: 
The single acute SAH case in this series was compli-
cated by intra-procedural aneurysm rupture during con-
comitant endosaccular coiling, without any permanent 
deficit, and a full neurological recovery. Published data 
with larger numbers of acutely ruptured aneurysms 
treated with PED caution that the technique should only 
be used if there is no other option, and that endosaccular 
coils should be deployed when possible [7,9,15,19,24]. 
10) In-construct stenosis: 
In-construct stenosis was only recorded in one patient 
which is at the lower range of published incidence 
[1,3,5,8,15]. 
11) Treatment of aneurysmal carotid-cavernous fistula 
with PED: 
The use of a PED construct to treat a direct caro-
tid-cavernous fistula (CCF) is a novel technique that has 
previously been described for treatment of a traumatic 
CCF [29], but not when secondary to aneurysm rupture, 
as was the case in Patient 13.  
12) Long-term clinical follow-up: 
At current follow-up (mean 21, range 13 - 32 months), 
2 (6%) of 33 patients have a neurological status that is 
worse than before their PED treatment; due to increased 
mass effect causing ophthalmoplegia (mRS 1), and pon-
tine infarction (mRS 2) respectively. Both of these events 
occurred in the short term at 24-hours and 11 days post 
PED treatment. No late complications and no deaths 
have occurred. 
Our minimum length of clinical follow-up (13 months) 
in 33 patients is the longest of any published series of 
greater than 20. Smaller series by Szikora et al. and 
Deutschmann, et al. of 18 and 12 cases respectively have 
also published 12-month clinical results [1,2]. The PUFS 
trial recorded 12 month clinical follow-up for 92 (85.2%) 
of 111 cases in the publicly accessible FDA documents, 
but these only record itemized numbers of clinical events 
without any explanation or discussion [5]. 
13) Other flow diverters: 
The SILK™ flow diverter (SFD, BALT Extrusion, 
Paris) is the other flow diverting construct currently 
available. Its concept is similar, however reports of de-
layed aneurysm rupture suggest a different safety profile 
to the PED [30-32]. 
Early SILK cases series also report higher overall 
complication rates than the equivalent early PED series. 
[3,8,33-37]. 
As well, MicroVention-TERUMO (Tustin, CA, USA) 
has recently introduced FRED™ (Flow Re-Direction 
Endoluminal Device), with the clinical trials and case 
series are underwent.  
5. CONCLUSION 
The technique of flow diversion and endoluminal recon-
struction differs greatly from the established endosaccu-
lar packing techniques of standard coiling, balloon re-
modeling, and stent assisted coiling. This is reflected in 
the different technical issues at deployment, aneurysm 
closure rates, and the spectrum of complications. As well 
as being associated with higher rates of aneurysm closure 
and lower rates of retreatment, PED is associated with an 
altered spectrum of complications relative to other tech-
niques. The rates of clinically significant complications 
compare favorably with published data on stent assisted 
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coiling. This study of 33 patients is the first of its size to 
present greater than 12-month clinical follow-up and 
analysis of complications. 
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